Clinical Trial: Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Neuroendocrine Tumors
Somatostatin Receptor-positive Neuroendocrine Tumor
Study Type: INTERVENTIONAL
Official Title: Dosimetry-Guided 177Lu-DOTATATE Treatment Planning Using 64Cu-DOTATATE as a Surrogate
Brief Summary:
The goal of this research is to determine if DetectnetTM PET/CT can be used to make Lutathera therapy safer for patients with neuroendocrine cancer.Participants will:* Complete two phases involving 6 visits* Undergo additional research PET/CT, and possibly SPECT/CT scans
Read more